Moore, M. C., Smith, M. S., Sinha, V. P., Beals, J. M., Michael, M. D., Jacober, S. J., & Cherrington, A. D. (2014). Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism. Diabetes.

Moore, Mary Courtney, Marta S. Smith, Vikram P. Sinha, John M. Beals, M. Dodson Michael, Scott J. Jacober, and Alan D. Cherrington. "Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect On Glucose Metabolism." Diabetes 2014.

Moore, Mary Courtney, et al. "Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect On Glucose Metabolism." Diabetes 2014.